Page last updated: 2024-08-18

pelargonic acid and Chronic Disease

pelargonic acid has been researched along with Chronic Disease in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Andersen, F; Andersen, KE; Bindslev-Jensen, C; Fullerton, A; Hedegaard, K; Petersen, TK1
Aldridge, RD; Forsey, RJ; Howie, SE; Hunter, JA; McVittie, E; Sands, C; Shahidullah, H1

Trials

1 trial(s) available for pelargonic acid and Chronic Disease

ArticleYear
Anti-irritants II: Efficacy against cumulative irritation.
    Contact dermatitis, 2006, Volume: 55, Issue:3

    Topics: Adult; Chemistry, Pharmaceutical; Chronic Disease; Dermatitis, Irritant; Dose-Response Relationship, Drug; Double-Blind Method; Fatty Acids; Fatty Acids, Monounsaturated; Female; Glycerol; Humans; Irritants; Male; Monocyclic Sesquiterpenes; Nifedipine; Rapeseed Oil; Reference Values; Sesquiterpenes; Sodium Dodecyl Sulfate; Surface-Active Agents; Water Loss, Insensible

2006

Other Studies

1 other study(ies) available for pelargonic acid and Chronic Disease

ArticleYear
Epidermal Langerhans cell apoptosis is induced in vivo by nonanoic acid but not by sodium lauryl sulphate.
    The British journal of dermatology, 1998, Volume: 139, Issue:3

    Topics: Adolescent; Adult; Antigens, CD1; Apoptosis; Cell Count; Cell Division; Cell Size; Chronic Disease; Dendritic Cells; Dermatitis, Irritant; Epidermis; Fatty Acids; Female; Humans; Langerhans Cells; Male; Middle Aged; Sodium Dodecyl Sulfate; Surface-Active Agents

1998